These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4587143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E, Mackaness GB.
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract] [Full Text] [Related]

  • 3. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E.
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T, Azuma I, Aladin AA, Yamamura Y.
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of two strains of BCG on transplantation immunity to SV40-induced tumors in hamsters.
    Fortner GW, Hanna MG, Coggin JH.
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):62-7. PubMed ID: 4373753
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice.
    Lachmann PJ, Sikora K.
    Nature; 1978 Feb 02; 271(5644):463-4. PubMed ID: 342968
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G, Halle-Pannenko O, Bourut C.
    Natl Cancer Inst Monogr; 1973 Dec 02; 39():107-13. PubMed ID: 4150738
    [No Abstract] [Full Text] [Related]

  • 14. BCG and cancer (first of two parts).
    Bast RC, Zbar B, Borsos T, Rapp HJ.
    N Engl J Med; 1974 Jun 20; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract] [Full Text] [Related]

  • 15. Activated macrophages and the antitumor action of BCG.
    Alexander P.
    Natl Cancer Inst Monogr; 1973 Dec 20; 39():127-33. PubMed ID: 4595313
    [No Abstract] [Full Text] [Related]

  • 16. The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cells.
    Olsson L, Ebbesen P, Kiger N, Florentin I, Mathé G.
    Eur J Cancer (1965); 1978 Apr 20; 14(4):355-62. PubMed ID: 348478
    [No Abstract] [Full Text] [Related]

  • 17. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO.
    Johns Hopkins Med J Suppl; 1974 Apr 20; 3():51-60. PubMed ID: 4370816
    [No Abstract] [Full Text] [Related]

  • 18. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL, Purnell DM, Kreider JW.
    Science; 1976 Jan 23; 191(4224):299-301. PubMed ID: 1108198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuraminidase-induced enhancement of tumor growth in mice.
    Froese G, Berczi I, Sehon AH.
    J Natl Cancer Inst; 1974 Jun 23; 52(6):1905-8. PubMed ID: 4834417
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.